发明名称 Exendin 4 polypeptide fragment
摘要 The present invention relates to an Exendin 4 polypeptide fragment, which has hypoglycemic activity, and can be used for the treatment of type II diabetes mellitus. The polypeptide sequence described herein is HGEGTX1TSDLSKQX2EEEAVX3LFIEWLKNGX<SUB>4</SUB>PX<SUB>5</SUB>, where X<SUB>1 </SUB>represents Phe or Tyr, X<SUB>2 </SUB>represents Met, Ile or Leu, X<SUB>3 </SUB>represents Lys, X<SUB>4 </SUB>represents Gly or deletion, X<SUB>5 </SUB>represents Arg or deletion. Additionally, the present invention relates to a method for the Exendin 4 polypeptide fragment preparation.
申请公布号 US2007037747(A1) 申请公布日期 2007.02.15
申请号 US20060497075 申请日期 2006.08.01
申请人 CHANGZHOU PHARMACEUTICAL FACTORY 发明人 MA XIAOPENG;WANG BING;XI SHAOQI
分类号 A61K38/22;C07K14/575 主分类号 A61K38/22
代理机构 代理人
主权项
地址